Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomaSakiko Harada, Norio Komatsu, Chansu Shin et al.|Molecular Therapy|2021Cited by 48
iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing SarcomaMidori Ishii, Miki Ando, Jun Ando et al.|Cancer Immunology Research|2021Cited by 19
Data from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing SarcomaMidori Ishii, Miki Ando, Jun Ando et al.|Unknown|2023Cited by 0
Supplementary Figure and Table from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing SarcomaMidori Ishii, Miki Ando, Jun Ando et al.|Unknown|2023Cited by 0
Data from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing SarcomaMidori Ishii, Miki Ando, Jun Ando et al.|Unknown|2023Cited by 0